ALSFRS
-
ALS, ALSFRS, ALSFRS-R, amyotrophic lateral sclerosis, clinical trial endpoints, functional decline, motor neuron disease, Neurodegenerative Diseases, neuroscience, ordinal outcome scales, PRO-ACT, Psychiatry, Psychology, Shannon entropy, Simpson’s paradoxALS Entropy Analysis Finds 5-Month Signal Hidden by ALSFRS Scores
A 2026 PRO-ACT analysis of amyotrophic lateral sclerosis (ALS) trial data found…
